- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02839005
Absorbable Suture Versus Nonabsorbable Suture Intradermal for the Skin Transverse Section in Cesarean
July 18, 2016 updated by: Roberta Junqueira Lima, Universidade do Vale do Sapucai
Context: Cesarean section is the most common surgery in women, both in developed and underdeveloped countries.
However results are conflicting report in which material for intradermal suturing get better aesthetic result.
Objective: To compare the aesthetic appearance of two suture materials, polyglecaprone 25 and polyamide (nylon) with intradermal sutures for skin closure in women undergoing cesarean section first.
Methods: This is a clinical, prospective and randomized study which was conducted in the Department of Gynecology and Obstetrics of a tertiary Institute, Hospital das Clinicas Samuel Libânio, in PousoAlegre, Estate of Minas Gerais.
Sixty women undergoing cesarean section were first included and randomized into two groups: group I (n = 30) polyamide and group II (n = 30) polyglecaprone 25.
Hypertrophy, color and width of the wound were evaluated, receiving a score, according to Trimbos table, six months after surgery.
Later the results were compared to non-parametric statistical tests
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Pouso Alegre, Minas Gerais, Brazil, 37550-000
- Hospital das Clínicas Samuel Libânio
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients who underwent cesarean section
- No restriction of ethnicity, education or social class
Exclusion Criteria:
- Scarring Pfannenstiel prior
- Diabetic patients using drugs;
- Patients with collagen diseases
- Patients with pre operative tests to indicate any systemic sign of infection or site, not previously treated until the time of surgery.
- Patients who withdrew informed consent
- Patients who did not attend the pre scheduled dates for the controls after surgery .
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: suture with polyglecaprone 25
|
At the end of surgical procedemento of cesarean delivery , for skin closure continuous suture was performed with polyglecaprone 25
|
|
Active Comparator: suture with polyamide (nylon)
|
At the end of surgical procedemento of cesarean delivery , for skin closure continuous suture was performed with polyamide (nylon)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Photographic documentation for evaluation
Time Frame: 6 Months
|
The photographic record was sent to three experts for evaluation of hypertrophy and cross marks staining points, according Trimboset al.,1993
|
6 Months
|
|
Photographic documentation for evaluation
Time Frame: 6 Months
|
The photographic record was sent to another expert for evaluation of hypertrophy and cross marks staining points, according Trimboset al.,1993, besides scar mesure
|
6 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
July 18, 2016
First Submitted That Met QC Criteria
July 18, 2016
First Posted (Estimate)
July 20, 2016
Study Record Updates
Last Update Posted (Estimate)
July 20, 2016
Last Update Submitted That Met QC Criteria
July 18, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MRJ
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.